Energizer Holdings, Inc. is rated Sell because its business metrics are worsening, including declining gross margins and rising costs of goods sold. Despite efforts to boost volume, revenues are flat or shrinking, and shareholder returns have dropped significantly due to lower dividends and buybacks, alongside dilution from stock-based compensation. The company's forward yield is less attractive than U.S. 10-year Treasury yields, reflecting concerns about margin compression and weak demand going forward. This suggests investors should be cautious about Energizer's stock given its current challenges and valuation.
Energizer's stock is the subject, with Pluang's Consumer Staples sector data providing context. Of 51 priced Consumer Staples-sector US stocks tradable on Pluang, 18 rose and 33 fell today. Notable movers include OTLY at USD 10.59 with a 1-day change of -3.02%, Estee Lauder Companies Inc (EL) at USD 90.04 with 100% sell order activity, and Conagra Brands Inc (CAG) at USD 13.13 with 100% buy order activity. This snapshot is as of Oct 02, 2026 01:32 WIB.
Foghorn Therapeutics saw its price target cut from $12 to $5 after it and Eli Lilly decided not to advance key cancer drug programs. The companies will not continue development of FHD-909 or a selective SMARCA2 degrader, ending their collaboration. F...
RPM International is set to report its Q3 2026 earnings on October 6, with analysts forecasting earnings per share of $1.95 and revenue of $2.22 billion, both higher than the previous year. Despite a slight recent dip in the EPS estimate, the report ...
Jefferies increased its price target for Regeneron to $930, citing an expanded partnership with Sanofi to develop four new long-acting antibodies targeting inflammatory pathways. Sanofi will pay Regeneron $1 billion upfront, with potential milestone ...
McCormick & Company reported fiscal Q3 results with adjusted EPS of $0.86, surpassing estimates of $0.76, and revenue of $2.02 billion, up 17.4% from last year. Growth was driven by the McCormick de Mexico acquisition, pricing actions, and favorable ...
Aehr Test Systems is set to report Q3 earnings of $0.11 per share and revenue around $27 million, marking a 1,000% increase in earnings year-over-year. The company projects fiscal 2027 revenue growth between 160% and 200%, reaching $130-$150 million,...
